Is Delcath Systems Inc (DCTH) undervalued? · P/E 1067, rev $37.2M
Delcath Systems Inc (DCTH) is a medical devices company listed on US.
This page asks whether Delcath Systems Inc (DCTH) looks cheap on cached numbers — not a DCF toy and not a buy alert.
Latest reported DCTH revenue for 2024-12-31 was $37.2M. Net income was -$26.4M. Revenue was up 1701.7% from 2023-12-31 to 2024-12-31. DCTH currently screens at market cap $368.3M and trailing P/E 1067.0.
DCTH currently screens at market cap $368.3M and trailing P/E 1067.0. Cheap versus history or peers still needs a filing reason; a low multiple can be a value trap.
A new DCTH 10-Q can flip this screen overnight. The SEC page is the source.
Not investment advice. Compare DCTH to the stock page model before you treat a low multiple as a gift.
Not investment advice.